Home
About
Overview
Sharing Data
ORCID
Help
History (37)
Carboxypeptidases
Pinellia
Occlusive Dressings
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.
CTLA-4 engagement regulates NF-kappaB activation in vivo.
See All 37 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CTLA-4 engagement regulates NF-kappaB activation in vivo.
CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol. 2002 Aug; 32(8):2095-104.
View in:
PubMed
subject areas
Abatacept
Animals
Antigens, CD
Antigens, Differentiation
CTLA-4 Antigen
DNA-Binding Proteins
I-kappa B Proteins
Immunoconjugates
Interleukin-2
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
NF-kappa B
NF-KappaB Inhibitor alpha
Pancreas
T-Lymphocytes
Transgenes
authors with profiles
Maria-Luisa Alegre